Show simple item record

dc.contributor.authorScherag, Aen_US
dc.contributor.authorSchöneweck, Fen_US
dc.contributor.authorKesselmeier, Men_US
dc.contributor.authorTaudien, Sen_US
dc.contributor.authorPlatzer, Men_US
dc.contributor.authorFelder, Men_US
dc.contributor.authorSponholz, Cen_US
dc.contributor.authorRautanen, Aen_US
dc.contributor.authorHill, AVSen_US
dc.contributor.authorHinds, CJen_US
dc.contributor.authorHossain, Hen_US
dc.contributor.authorSuttorp, Nen_US
dc.contributor.authorKurzai, Oen_US
dc.contributor.authorSlevogt, Hen_US
dc.contributor.authorGiamarellos-Bourboulis, EJen_US
dc.contributor.authorArmaganidis, Aen_US
dc.contributor.authorTrips, Een_US
dc.contributor.authorScholz, Men_US
dc.contributor.authorBrunkhorst, FMen_US
dc.date.accessioned2019-07-23T12:57:58Z
dc.date.available2016-08-27en_US
dc.date.issued2016-10en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/58621
dc.description.abstractSepsis is the dysregulated host response to an infection which leads to life-threatening organ dysfunction that varies by host genomic factors. We conducted a genome-wide association study (GWAS) in 740 adult septic patients and focused on 28day mortality as outcome. Variants with suggestive evidence for an association (p≤10-5) were validated in two additional GWA studies (n=3470) and gene coding regions related to the variants were assessed in an independent exome sequencing study (n=74). In the discovery GWAS, we identified 243 autosomal variants which clustered in 14 loci (p≤10-5). The best association signal (rs117983287; p=8.16×10-8) was observed for a missense variant located at chromosome 9q21.2 in the VPS13A gene. VPS13A was further supported by additional GWAS (p=0.03) and sequencing data (p=0.04). Furthermore, CRISPLD2 (p=5.99×10-6) and a region on chromosome 13q21.33 (p=3.34×10-7) were supported by both our data and external biological evidence. We found 14 loci with suggestive evidence for an association with 28day mortality and found supportive, converging evidence for three of them in independent data sets. Elucidating the underlying biological mechanisms of VPS13A, CRISPLD2, and the chromosome 13 locus should be a focus of future research activities.en_US
dc.description.sponsorshipThe project was supported by the Paul-Martini-Sepsis Research Group, funded by the Thuringian Ministry of Education, Science and Culture (ProExcellence; grant PE 108-2); the public funded Thuringian Foundation for Technology, Innovation and Research (STIFT) and the German Sepsis Society (GSS); the Jena Center of Sepsis Control and Care (CSCC), funded by the German Ministry of Education and Research (BMBF; 01 EO 1002, 01 EO 1502). The VISEP and MAXSEP trials from the SepNet Study Group had been supported by a BMBF grant (01 KI 0106) and by unrestricted grants from B. Braun, HemoCue, Novo Nordisk, Astra Zeneca GmbH, Wedel, Germany and Bayer HealthCare, Leverkusen, Germany. The exome sequencing study was funded in part by the Hellenic Institute for the Study of Sepsis. The GenOSept study was supported by the European Union and benefits from the 6th framework programme of RTD funding. The PROGRESS study is supported by the German Federal Ministry of Education and Research, grant numbers 01KI07110 (Giessen), 01KI07111 (Jena), 01KI07113 (Leipzig), 01KI07114 (Berlin), 01KI1010I (Leipzig), and 01KI1010D (Greifswald).en_US
dc.format.extent239 - 246en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofEBioMedicineen_US
dc.rightsCreative Commons Attribution License*
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectExomeen_US
dc.subjectGenome-wide association studyen_US
dc.subjectHost responseen_US
dc.subjectMortalityen_US
dc.subjectSepsisen_US
dc.subjectChromosome Mappingen_US
dc.subjectCohort Studiesen_US
dc.subjectDisease Progressionen_US
dc.subjectExomeen_US
dc.subjectFemaleen_US
dc.subjectGenetic Predisposition to Diseaseen_US
dc.subjectGenetic Variationen_US
dc.subjectGenome-Wide Association Studyen_US
dc.subjectGenomicsen_US
dc.subjectHigh-Throughput Nucleotide Sequencingen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMortalityen_US
dc.subjectPolymorphism, Single Nucleotideen_US
dc.subjectPrognosisen_US
dc.subjectQuantitative Trait Locien_US
dc.subjectReproducibility of Resultsen_US
dc.subjectSepsisen_US
dc.subjectTime Factorsen_US
dc.titleGenetic Factors of the Disease Course after Sepsis: A Genome-Wide Study for 28Day Mortality.en_US
dc.typeArticle
dc.rights.holder2016 The Authors. Published by Elsevier B.V.
dc.identifier.doi10.1016/j.ebiom.2016.08.043en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/27639821en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume12en_US
dcterms.dateAccepted2016-08-27en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution License
Except where otherwise noted, this item's license is described as Creative Commons Attribution License